Ribomic Inc. (4591.T)
JPY 88.0
(-1.12%)
JPY 88.0
(-1.12%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.02 Billion JPY | 38.04% |
| 2022 | -1.65 Billion JPY | 1.88% |
| 2021 | -1.68 Billion JPY | -41.91% |
| 2020 | -1.18 Billion JPY | -38.85% |
| 2019 | -855 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -254 Million JPY | -14.69% |
| 2023 Q1 | -334.99 Million JPY | -89.99% |
| 2023 Q2 | -219.87 Million JPY | 34.36% |
| 2023 Q4 | -221.47 Million JPY | 10.66% |
| 2023 Q3 | -247.9 Million JPY | -12.75% |
| 2023 FY | -1.02 Billion JPY | 38.04% |
| 2022 Q3 | -598.01 Million JPY | -125.36% |
| 2022 FY | -1.65 Billion JPY | 1.88% |
| 2022 Q4 | -176.32 Million JPY | 70.52% |
| 2022 Q2 | -265.35 Million JPY | 0.0% |
| 2021 FY | -1.68 Billion JPY | -41.91% |
| 2020 FY | -1.18 Billion JPY | -38.85% |
| 2019 FY | -855 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 366.728% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -94.384% |
| GNI Group Ltd. | 8.09 Billion JPY | 112.654% |
| Linical Co., Ltd. | 338.26 Million JPY | 402.79% |
| Trans Genic Inc. | 4.08 Million JPY | 25173.121% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 28.771% |
| Soiken Holdings Inc. | -662.2 Million JPY | -54.671% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 841.368% |
| AnGes, Inc. | -7.43 Billion JPY | 86.229% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 20.487% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 85.761% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 648.618% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -31.312% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 11.16% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 15.282% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -26.074% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -216.453% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 16.047% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 27.976% |
| PeptiDream Inc. | 3.03 Billion JPY | 133.738% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 47.164% |
| SanBio Company Limited | -2.64 Billion JPY | 61.262% |
| Healios K.K. | -3.82 Billion JPY | 73.209% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 12.315% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 31.241% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 28.345% |
| StemRIM | -2.02 Billion JPY | 49.345% |
| CellSource Co., Ltd. | 923.14 Million JPY | 210.951% |
| FunPep Company Limited | -933.41 Million JPY | -9.73% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -19.913% |
| Stella Pharma Corporation | -763.74 Million JPY | -34.106% |
| TMS Co., Ltd. | -960.04 Million JPY | -6.687% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 9.361% |
| Cuorips Inc. | -632.18 Million JPY | -62.016% |
| K Pharma,Inc. | 260.33 Million JPY | 493.438% |
| Takara Bio Inc. | 1.48 Billion JPY | 169.205% |
| ReproCELL Incorporated | -31.41 Million JPY | -3160.344% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3982.921% |
| StemCell Institute Inc. | 310.98 Million JPY | 429.357% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 815.404% |
| CellSeed Inc. | -846.53 Million JPY | -20.992% |